back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-08-13 14:10 Tx date 2025-08-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$29,813
+745,341 vol $0.04 each |
5,256,094 | |
| Filed 2025-08-13 14:10 Tx date 2025-08-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+250,000 vol $0.04 each |
4,510,753 | |
| Filed 2025-08-13 14:09 Tx date 2025-08-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,428
+60,723 vol $0.04 each |
4,260,753 | |
| Filed 2025-08-12 14:09 Tx date 2025-08-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,000
+250,000 vol $0.04 each |
4,200,030 | |
| Filed 2025-08-12 14:08 Tx date 2025-08-11 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$9,500
+250,000 vol $0.038 each |
3,950,030 | |
| Filed 2025-08-12 14:06 Tx date 2025-08-08 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$20,000
+500,000 vol $0.04 each |
3,700,030 | |
| Filed 2025-06-16 17:10 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$37,500
+750,000 vol $0.05 each |
4,150,000 | |
| Filed 2025-06-16 17:06 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Klass, Russell Kevin
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
2,700,000 | |
| Filed 2025-06-16 17:03 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Heaton, Larry C.
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$200,000
+4,000,000 vol $0.05 each |
18,000,000 | |
| Filed 2025-06-16 16:57 Tx date 2025-06-12 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
DeHaan-Fullerton, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$25,000
+500,000 vol $0.05 each |
1,500,000 | |
| Filed 2025-05-21 16:20 Tx date 2025-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,187
+63,750 vol $0.05 each |
1,000,000 | |
| Filed 2025-05-21 16:19 Tx date 2025-05-21 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Blair, Tony
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,776
+36,250 vol $0.049 each |
936,250 | |
| Filed 2025-05-20 16:12 Tx date 2025-05-19 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
DeHaan-Fullerton, Karen
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$5,006
+104,300 vol $0.048 each |
104,300 | |
| Filed 2025-05-20 16:07 Tx date 2025-05-19 |
$ZOMDF
Zomedica Corp. (formerly Zomedica Pharmaceuticals Corp.) |
Powers, Johnny
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$23,000
+500,000 vol $0.046 each |
3,425,000 |